Search

Your search keyword '"S. Auer"' showing total 300 results

Search Constraints

Start Over You searched for: Author "S. Auer" Remove constraint Author: "S. Auer"
300 results on '"S. Auer"'

Search Results

251. "The King is dead": Checkmating ion channels with tethered toxins.

252. Efficient high-quality volume rendering of SPH data.

253. Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

254. Insight into the correlation between lag time and aggregation rate in the kinetics of protein aggregation.

255. Differences in the kinetics of gamma-H2AX fluorescence decay after exposure to low and high LET radiation.

256. Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England.

257. Nucleation of amyloid fibrils.

258. An in vivo tethered toxin approach for the cell-autonomous inactivation of voltage-gated sodium channel currents in nociceptors.

259. Phase diagram of alpha-helical and beta-sheet forming peptides.

260. Silencing neurotransmission with membrane-tethered toxins.

261. An antibody surface for selective neuronal cell attachment.

262. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy.

263. CMOS-integrated film bulk acoustic resonators for label-free biosensing.

264. No evidence for a different RBE between pulsed and continuous 20 MeV protons.

265. Essential role of the C-terminus in Melanocarpus albomyces laccase for enzyme production, catalytic properties and structure.

266. Manipulating neuronal circuits with endogenous and recombinant cell-surface tethered modulators.

267. Structure-function studies of a Melanocarpus albomyces laccase suggest a pathway for oxidation of phenolic compounds.

268. A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation.

269. Functional characterisation of Fab'-fragments self-assembled onto hydrophilic gold surfaces.

270. Self-templated nucleation in peptide and protein aggregation.

271. A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates.

272. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush.

273. Characteristics of a dust trajectory sensor.

274. Importance of metastable states in the free energy landscapes of polypeptide chains.

275. Characterization of the nucleation barriers for protein aggregation and amyloid formation.

276. Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass.

277. Large area mass analyzer instrument for the chemical analysis of interstellar dust particles.

278. Breakdown of classical nucleation theory near isostructural phase transitions.

279. Crystal nucleation of colloidal suspensions under shear.

280. Onset of heterogeneous crystal nucleation in colloidal suspensions.

281. Numerical prediction of absolute crystallization rates in hard-sphere colloids.

282. Quantitative prediction of crystal-nucleation rates for spherical colloids: a computational approach.

283. [Central case management in surgery].

284. Line tension controls wall-induced crystal nucleation in hard-sphere colloids.

285. Phase behavior and crystallization kinetics of poly-12-hydroxystearic-coated polymethylmethacrylate colloids.

286. [Central patient management in surgery].

287. Suppression of crystal nucleation in polydisperse colloids due to increase of the surface free energy.

288. Prediction of absolute crystal-nucleation rate in hard-sphere colloids.

289. Progression of Alzheimer's disease: variability and consistency: ontogenic models, their applicability and relevance.

290. The use of Baypamun N in crowding-associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 2-week-old veal calves.

291. The GDS/FAST staging system.

292. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.

293. Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease.

294. Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines.

296. Dyphylline aerosol can induce bronchospasm in human asthmatics.

298. Polarization-sensitive spectroradiometer: two methods for overcoming the problems of measuring reflectance spectra.

300. [Surgery of Crohn's disease].

Catalog

Books, media, physical & digital resources